CLPT director settles 12,417 RSUs into shares
ClearPoint Neuro director Linda M. Liau acquired 12,417 shares of common stock through settlement of restricted stock units.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
ClearPoint Neuro director Linda M. Liau acquired 12,417 shares of common stock through settlement of restricted stock units. These RSUs were granted on May 22, 2025 and vested on their scheduled date, converting into the same number of common shares. After this compensation-related transaction, she holds 64,801 shares of ClearPoint Neuro common stock directly. No open-market buys or sells were reported in this filing.
Insider Trade Summary
12,417 shares exercised/converted
Exercise
2 txns
Insider
LIAU LINDA M.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 12,417 | $0.00 | $0.00 |
| Exercise | Common Stock | 12,417 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 0 contracts (Direct);
Common Stock — 64,801 shares (Direct)
Holdings Before and After:
Restricted Stock Units, 12,417 to 0 contracts (Direct);
Common Stock, 52,384 to 64,801 shares (Direct)
Footnotes (1)
- F1. Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
Key Figures
RSUs settled: 12,417 shares
Shares acquired: 12,417 shares
Post-transaction holdings: 64,801 shares
+2 more
5 metrics
RSUs settled
12,417 shares
Restricted stock units vesting into common stock
Shares acquired
12,417 shares
Common stock received from RSU settlement
Post-transaction holdings
64,801 shares
Common stock held directly after transaction
RSU grant date
May 22, 2025
Grant date for 12,417 restricted stock units
RSU-to-share ratio
1 RSU : 1 share
Each RSU represents one share of CLPT common stock
Key Terms
Restricted Stock Units, derivative security, vested, annual meeting of stockholders
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction code description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vested financial
"This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."
annual meeting of stockholders financial
"vesting on the earlier of the first anniversary of the grant date, or the day immediately preceding the Company's 2026 annual meeting of stockholders."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CLPT director Linda M. Liau report on this Form 4?
Linda M. Liau reported the settlement of 12,417 restricted stock units into 12,417 shares of ClearPoint Neuro common stock. This reflects scheduled vesting of equity compensation, rather than an open-market stock purchase or sale.
What are the post-transaction holdings of Linda M. Liau in ClearPoint Neuro (CLPT)?
Following the RSU settlement, Linda M. Liau directly holds 64,801 shares of ClearPoint Neuro common stock. This figure reflects her updated ownership position after the 12,417 vested restricted stock units converted into common shares.
What was the original grant date and vesting terms of the CLPT restricted stock units?
The 12,417 restricted stock units were granted on May 22, 2025. They vested on the earlier of the first anniversary of the grant date or the day immediately preceding ClearPoint Neuro’s 2026 annual meeting of stockholders.
Does this CLPT Form 4 indicate any remaining restricted stock units for Linda M. Liau?
This Form 4 shows that 12,417 restricted stock units were fully settled into common shares, leaving zero RSUs from this grant. The derivative summary in the filing does not list any remaining derivative positions for this transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
